Sorafenib or Sunitinib

DRUG2 trials

Sponsors

Sun Yat-sen University, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Conditions

Gastrointestinal CancersRenal Cancer Cell

Phase 2

Third Line TKI After 2 TKIs in Patients With mRCC (Tokio Study)

TerminatedNCT03456401

Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoRenal Cancer Cell

Start: 2014-11-30End: 2017-11-08Updated: 2018-03-07

Unknown Phase

A Pilot Study of Genomic Sequencing Guided Individualized Therapy in Gastrointestinal Cancers, GITIC Study

Sun Yat-sen UniversityGastrointestinal Cancers

Start: 2013-12-31End: 2017-12-31Target: 50Updated: 2016-08-30